BioSpace News Archive

Complement-targeted Therapeutics Market: Competitive Analysis and Key Developments

Complement-targeted therapeutics are therapeutics that modulate the complement system. The complement-targeted therapeutics market has begun attracting clinical potential due to the observation that complement activation is a part of numerous inflammatory diseases.

October 12, 2020
·
5 min read
Cranial Closure and Fixation Devices Market: Increasing Road Accidents and Skull Deformities to Support High Demand

Cranium refers to a vital body part that offers hard protective covering to the brain and assists in the maintenance in the shape and size of the head.

October 12, 2020
·
5 min read
COVID-19 Detection Kits Market Growing Efforts to Introduce Advanced Testing Technologies

In recent months, there is a striking increase in the spread of COVID-19 infection in all worldwide locations.

October 12, 2020
·
3 min read
Dental Anesthetics Market: Growth in Investments on Dental Research Activities is Opening New Avenues for the Market Expansion

Rising number of worldwide population living with dental issues is foreseen to stimulate prodigious demand avenues in the global dental anesthetics market during 2020–2030.

October 12, 2020
·
5 min read
Medical Face Shield Market: Rising instances of COVID-19 patients worldwide is fueling the market demand

The global medical face shield market is likely to break all records of revenues generation during the forecast period of 2020–2030.

October 12, 2020
·
4 min read
Nasal Polyps Treatment Market: Rise in Prevalence of CRSwNP across the Globe to Drive Market

Transparency Market Research has published a new report on the nasal polyps treatment market for the forecast period of 2019 - 2027.

October 12, 2020
·
6 min read
Policy

Valor Compounding Pharmacy™ Earns PCAB® Seal of Accreditation

Valor Compounding Pharmacy™ is proud to announce that it has earned the Pharmacy Compounding Accreditation Board’s Seal of Accreditation, which demonstrates the company has met the highest standards of quality and safety in the compounding pharmacy profession.

October 12, 2020
·
3 min read
Policy

With the priority review underway at FDA, Oncopeptides moves forward with intent to file for conditional approval of melflufen with EMA

Oncopeptides AB announces that the Company has informed the European Medicines Agency, EMA, about its intention to submit an application for a conditional marketing authorization of melflufen in the EU, based on the pivotal phase 2 HORIZON study in relapsed refractory multiple myeloma.

October 12, 2020
·
4 min read
Business

Cambrex Completes Major Expansion of Solid Form Screening Facility in Edinburgh

Cambrex, announced the completion of an expansion of its solid form screening and crystallization process development facility in Edinburgh, Scotland.

October 12, 2020
·
2 min read
Drug Development

TREMFYA® (guselkumab) Induces Clinical and Endoscopic Improvements in Patients with Moderately to Severely Active Crohn’s Disease based on Interim Results from Phase 2 Study

Interim analyses from GALAXI 1 study presented as an oral presentation at the United European Gastroenterology Week Virtual 2020 Congress

October 12, 2020
·
13 min read